|
101 |
Multi-omics characterization of the monkeypox virus infection Enthalten in Nature Communications Bd. 15, 8.8.2024, Nr. 1, date:12.2024: 1-19
|
|
|
102 |
Multi-proteomic profiling of the varicella-zoster virus–host interface reveals host susceptibilities to severe infection Enthalten in Nature microbiology Bd. 10, 30.7.2025, Nr. 8, date:8.2025: 2048-2072
|
|
|
103 |
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants Enthalten in Communications biology Bd. 5, 12.11.2022, Nr. 1, date:12.2022: 1-7
|
|
|
104 |
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection Enthalten in AIDS research and therapy Bd. 7, 2.7.2010, Nr. 1, date:12.2010: 1-13
|
|
|
105 |
SARS-CoV-2 serology increases diagnostic accuracy in CT-suspected, PCR-negative COVID-19 patients during pandemic Enthalten in Respiratory research Bd. 22, 23.4.2021, Nr. 1, date:12.2021: 1-10
|
|
|
106 |
Single cell polarity in liquid phase facilitates tumour metastasis Enthalten in Nature Communications Bd. 9, 28.2.2018, Nr. 1, date:12.2018: 1-20
|
|
|
107 |
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring Enthalten in Journal of translational medicine Bd. 14, 14.6.2016, Nr. 1, date:12.2016: 1-12
|
|
|
108 |
Viral genome sequencing to decipher in-hospital SARS-CoV-2 transmission events Enthalten in Scientific reports Bd. 14, 8.3.2024, Nr. 1, date:12.2024: 1-11
|
|
|
109 |
Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment Enthalten in BMC microbiology Bd. 12, 28.12.2012, Nr. 1, date:12.2012: 1-10
|
|